NRIX
Nurix Therapeutics, Inc. Healthcare - Biotechnology Investor Relations →
Nurix Therapeutics, Inc. (NRIX) closed at $16.85 as of 2026-02-02, trading 24.8% above its 200-week moving average of $13.51. The stock moved further from the line this week, up from 22.4% last week. The 14-week RSI sits at 64, indicating neutral momentum.
Over the past 241 weeks of data, NRIX has crossed below its 200-week moving average 4 times. On average, these episodes lasted 46 weeks. The average one-year return after crossing below was -55.7%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $1733 million, NRIX is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -49.6%. The stock trades at 3.2x book value.
Share count has increased 115.8% over three years, indicating dilution.
Over the past 4.8 years, a hypothetical investment of $100 in NRIX would have grown to $66, compared to $172 for the S&P 500. NRIX has returned -8.5% annualized vs 12.1% for the index, underperforming the broader market over this period.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: NRIX vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After NRIX Crosses Below the Line?
Across 4 historical episodes, buying NRIX when it crossed below its 200-week moving average produced an average return of -37.5% after 12 months (median -48.0%), compared to -4.5% for the S&P 500 over the same periods. 25% of those episodes were profitable after one year. After 24 months, the average return was -70.0% vs +4.3% for the index.
Each line shows $100 invested at the moment NRIX crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
NRIX has crossed below its 200-week MA 4 times with an average 1-year return of +-55.7% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jun 2021 | Aug 2021 | 7 | 20.9% | -48.2% | -34.4% |
| Sep 2021 | Oct 2021 | 4 | 12.0% | -58.3% | -46.1% |
| Nov 2021 | Jun 2024 | 134 | 78.6% | -60.5% | -43.9% |
| Feb 2025 | Nov 2025 | 39 | 44.1% | N/A | -0.1% |
| Average | 46 | — | +-55.7% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02